Chanelle are delighted to announce the company has been shortlisted in the 2016 Pharma Company of the Year Awards (Large) in Ireland.
Commenting on the announcement, Michael Burke, MD said, “Our customers are the foundation of our success and I would like to take this opportunity to sincerely thank them for their continuous support and encouragement.”
The company is also shortlisted for Pharma Project of the Year for their development of super generic, Rheumocam® (Meloxicam) Granules – a new formulation of an existing molecule, Meloxicam.
An independent panel of recognised and expert judges representing the Pharma industry will assess all applications and determine the winners at an Awards Ceremony in Dublin on October 13th 2016. For more information visit www.pharmaawards.ie
Chanelle would like to wish all the nominees the best of luck.